20
2014
Diverging trends in incidence of HIV versus other sexually transmitted infections in HIV-negative MSM in Amsterdam.

Ward P.H. van Bilsen , Anders Boyd , Maarten F.S. van der Loeff , Udi Davidovich
AIDS 34 ( 2) 301 -309

13
2020
Evaluation of a new rapid diagnostic kit (FemExam) for bacterial vaginosis in patients with vaginal discharge syndrome in The Gambia.

BERYL WEST , LINDA MORISON , MAARTEN SCHIM VAN DER LOEFF , EUPHEMIA GOODING
Sexually Transmitted Diseases 30 ( 6) 483 -489

49
2003
HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007.

Carla van Tienen , Maarten van der Loeff , Ingrid Peterson , Matthew Cotten
Retrovirology 7 ( 1) 50 -50

20
2010
Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village

MF van der Loeff , N Larke , S Kaye , N Berry
Retrovirology 7 ( 1) 46 -46

64
2010
Plasma viral load and CD4% also predict mortality in HIV-2 infection. Cohort study with 8 year follow-up in West Africa

Maarten van der Loeff , Andreas Hansmann , Steve Kaye , Akum Awasana
Tropical Medicine & International Health 8 ( 11)

2003
The neurology of HTLV-1 infection

S A Cooper , M S. van der Loeff , G P Taylor
Practical Neurology 9 ( 1) 16 -26

59
2009
HPV SEROSTATUS PRE- AND POST-VACCINATION IN A RANDOMIZED PHASE II PREPAREDNESS TRIAL AMONG YOUNG WESTERN CAPE, SOUTH AFRICAN WOMEN: THE EVRI TRIAL.

Staci L. Sudenga , B. Nelson Torres , Matthys H. Botha , Michele Zeier
Papillomavirus Research 3 50 -56

4
2017
Cervical HPV natural history among young Western Cape, South African women: The randomized control EVRI Trial.

Staci L. Sudenga , B. Nelson Torres , Matthys H. Botha , Michele Zeier
Journal of Infection 72 ( 1) 60 -69

6
2016
No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients.

Assan Jaye , Ramu Sarge‐Njie , Maarten Schim van der Loeff , Jim Todd
The Journal of Infectious Diseases 189 ( 3) 498 -505

30
2004
Solithromycin for the treatment of drug-resistant gonorrhoea

Henry J C de Vries , Maarten F Schim-van der Loeff
The Lancet Infectious Diseases 19 ( 8) 791 -792

1
2019
P1-S5.27 Low prevalence of asymptomatic STI in HIV-infected heterosexual males and females, visiting an HIV outpatient clinic in the Netherlands

M. Heiligenberg , M. S. van der Loeff , H. de Vries , S. Geerlings
Sexually Transmitted Infections 87

2011
O1-S10.04 Lifestyle as marker of Hepatitis C infection in HIV infected MSM in Amsterdam, The Netherlands

A. Matser , R. Geskus , T. Heijman , A. Urbanus
Sexually Transmitted Infections 87

2011
Behaviour change and competitive exclusion can explain the diverging HIV-1 and HIV-2 prevalence trends in Guinea-Bissau.

Wolf-Peter Schmidt , M Schim Van Der Loeff , P Aaby , Hilton Whittle
Epidemiology and Infection 136 ( 4) 551 -561

22
2008
P2.18 The value of light microscopy to diagnose urogenital gonorrhoea in indonesian clinic-based and outreach sexually transmitted infections services

IPutu Yuda Hananta , Alje PVan Dam , Sylvia Maria Bruisten , Maarten Franciscus Schim Van Der Loeff
Sexually Transmitted Infections 93

2017
O05.2 Pharyngeal gonococcal infection: spontaneous clearance and persistence after treatment

IPutu Yuda Hananta , Henry John Christiaan De Vries , Alje P Van Dam , Martijn Sebastiaan Van Rooijen
Sexually Transmitted Infections 93

2017